Get the Stockscreener App
7.60
7.43%
-0.61
After Hours:
7.63
0.03
+0.39%
Briacell Therapeutics Corp stock is traded at $7.60, with a volume of 100.61K.
It is down -7.43% in the last 24 hours and up +850.71% over the past month.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
See More
Previous Close:
$8.21
Open:
$8.3
24h Volume:
100.61K
Relative Volume:
0.08
Market Cap:
$14.41M
Revenue:
-
Net Income/Loss:
$-16.60M
P/E Ratio:
-8.5393
EPS:
-0.89
Net Cash Flow:
$-23.48M
1W Performance:
+1,001%
1M Performance:
+850.71%
6M Performance:
+100.00%
1Y Performance:
-37.43%
1-Day Range:
$7.45
$8.435
1-Week Range:
$0.6311
$8.52
52-Week Range:
$0.61
$29.40
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
7.60 | 14.41M | 0 | -16.60M | -23.48M | -0.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Can BriaCell Therapeutics Corp. recover in the next quarterMarket Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Using portfolio simulators with BriaCell Therapeutics Corp. includedVolume Spike & Weekly High Potential Alerts - Newser
Technical signs of recovery in BriaCell Therapeutics Corp. Equity WarrantNew Guidance & Safe Entry Momentum Tips - Newser
How to monitor BriaCell Therapeutics Corp. with trend dashboardsJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Technical analysis overview for BriaCell Therapeutics Corp. stockGlobal Markets & High Accuracy Buy Signal Tips - Newser
Published on: 2025-08-27 16:03:08 - Newser
What does recent volatility data suggest for BriaCell Therapeutics Corp. Equity WarrantWeekly Investment Report & Verified Stock Trade Ideas - Newser
Using economic indicators to assess BriaCell Therapeutics Corp. Equity Warrant potentialJuly 2025 Rallies & Technical Pattern Alert System - Newser
Why BriaCell Therapeutics Corp. Equity Warrant is moving todayWeekly Investment Report & Safe Capital Growth Tips - Newser
Using R and stats models for BriaCell Therapeutics Corp. forecastingPortfolio Gains Report & Real-Time Sentiment Analysis - Newser
How high can BriaCell Therapeutics Corp. Equity Warrant stock go2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Using flow based indicators on BriaCell Therapeutics Corp.Forecast Cut & Daily Entry Point Trade Alerts - Newser
News impact scoring models applied to BriaCell Therapeutics Corp. Equity WarrantRecession Risk & Verified Momentum Watchlists - Newser
Visual analytics tools that track BriaCell Therapeutics Corp. performanceDay Trade & AI Driven Stock Price Forecasts - Newser
Custom strategy builders for tracking BriaCell Therapeutics Corp.Inflation Watch & Daily Oversold Bounce Ideas - Newser
How hedge fund analytics apply to BriaCell Therapeutics Corp. Equity Warrant stockJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Is BriaCell Therapeutics Corp. Equity Warrant stock reversal real or fakeEarnings Recap Summary & High Return Stock Watch Alerts - Newser
Applying big data sentiment scoring on BriaCell Therapeutics Corp. Equity WarrantTrade Exit Summary & AI Forecast for Swing Trade Picks - Newser
BriaCell Therapeutics (BCTX) Stock Rating and Price Target Update | BCTX Stock News - GuruFocus
BriaCell Therapeutics Corp. stock retracement – recovery analysisSell Signal & Daily Oversold Stock Bounce Ideas - Newser
Evaluating BriaCell Therapeutics Corp. Equity Warrant with trendline analysisJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
What’s the recovery path for long term holders of BriaCell Therapeutics Corp. Equity Warrant2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
How sentiment analysis helps forecast BriaCell Therapeutics Corp.July 2025 Retail & Free Reliable Trade Execution Plans - Newser
Can BriaCell Therapeutics Corp. hit a new high this monthAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Using fundamentals and technicals on BriaCell Therapeutics Corp.Quarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Signal strength of BriaCell Therapeutics Corp. Equity Warrant stock in tech scannersShare Buyback & Growth Focused Stock Pick Reports - Newser
BriaCell Therapeutics Corp. stock daily chart insightsJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
BriaCell’s Bria-OTS+ Platform Validated in Cancer Journal - TipRanks
BriaCell Therapeutics : Investor Presentation (20250826 Investor Presentation) - MarketScreener
BriaCell Therapeutics Corp. stock momentum explainedTrend Reversal & Safe Investment Capital Preservation Plans - Newser
What recovery options are there for BriaCell Therapeutics Corp. Equity WarrantJuly 2025 Market Mood & Verified Technical Trade Signals - Newser
Real time alert setup for BriaCell Therapeutics Corp. performance2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Is BriaCell Therapeutics Corp. stock ready for a breakoutWeekly Investment Summary & Consistent Income Trade Ideas - Newser
Applying Wyckoff theory to BriaCell Therapeutics Corp. stockJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-08-26 10:47:43 - Newser
Stocks In Play - Baystreet.ca
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell Therapeutics Corp. - Baystreet.ca
MACD Signals Flash Warning for BriaCell Therapeutics Corp. Equity Warrant Stock getLinesFromResByArray error: size == 0 - kangso.co.kr
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal - GlobeNewswire
Breakthrough Cancer Treatment Mechanism: BriaCell and NCI Validate Novel Immunotherapy Platform in Major Study - Stock Titan
BriaCell Secures $2 Million Grant for Prostate Cancer Immunotherapy - MSN
How BriaCell Therapeutics Corp. Equity Warrant stock performs during market volatility2025 Key Lessons & Risk Controlled Stock Alerts - Newser
BriaCell Announces Share Consolidation to Meet Nasdaq Requirements - MSN
BriaCell Therapeutics Corp. Announces that it has been Awarded $2 Million NCI Grant to Advance Bria-PROS+ in Prostate Cancer - MarketScreener
BriaCell Therapeutics Awarded US$2 Million Grant to Advance Prostate Cancer Treatment - MarketScreener
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):